tiprankstipranks
Trending News
More News >
Innovent Biologics (IVBXF)
OTHER OTC:IVBXF

Innovent Biologics (IVBXF) Revenue

Compare
48 Followers

Innovent Biologics Revenue

Innovent Biologics had a revenue of 5.95B in the quarter ending Jun 30, 2025, with 8.84%. This bring the company's revenue in the last twelve months to 11.42B, Decreased 21.24%. In the fiscal year ending Dec 31, 2024, Innovent Biologics had annual revenue of 9.42B with 51.82% growth.
Revenue (ttm)
11.42B
Revenue Growth
P/S Ratio
1.91
Revenue/Employee
$1,664,939
Employees
5,659
Market Cap
$17.96B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
9.42B3.22B+51.82%
Dec 31, 2023
6.21B1.65B+36.21%
Dec 31, 2022
4.56B286.65M+6.71%
Dec 31, 2021
4.27B425.91M+11.08%
Dec 31, 2020
3.84B2.80B+266.94%
Dec 31, 2019
1.05B1.04B+10,953.34%
Dec 31, 2018
9.48M-9.06M-48.88%
Dec 31, 2017
18.54M